LUCISANO, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 549
EU - Europa 474
AS - Asia 244
OC - Oceania 1
Totale 1.268
Nazione #
US - Stati Uniti d'America 547
IE - Irlanda 158
CN - Cina 153
SE - Svezia 141
IT - Italia 59
SG - Singapore 53
DE - Germania 46
IN - India 24
FI - Finlandia 23
GB - Regno Unito 17
CZ - Repubblica Ceca 10
FR - Francia 5
VN - Vietnam 5
UA - Ucraina 4
CH - Svizzera 3
ID - Indonesia 2
PL - Polonia 2
TH - Thailandia 2
TR - Turchia 2
BE - Belgio 1
CA - Canada 1
ES - Italia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 1.268
Città #
Chandler 161
Dublin 158
Nyköping 87
Beijing 62
Singapore 40
Jacksonville 30
Ashburn 28
New York 24
Bremen 22
Cambridge 22
Medford 22
Messina 22
Princeton 22
Dearborn 21
Des Moines 18
Shenyang 16
San Mateo 13
Ann Arbor 12
Jinan 12
Pune 12
Boardman 11
Hyderabad 11
Brno 10
Nanjing 8
Ningbo 8
Hangzhou 7
Los Angeles 7
Munich 6
Hebei 5
Manchester 5
Seattle 5
Tianjin 5
Woodbridge 5
Dong Ket 4
Jiaxing 4
Lancaster 4
Nottingham 4
Catania 3
Fuzhou 3
Helsinki 3
Newbury Park 3
Siracusa 3
Taizhou 3
Zhengzhou 3
Bangkok 2
Basicò 2
Houston 2
Jakarta 2
Lentini 2
Miami 2
Nanchang 2
Warsaw 2
Wilmington 2
Zonguldak 2
Zurich 2
Amsterdam 1
Auckland 1
Berlin 1
Bishkek 1
Brussels 1
Clearwater 1
Clifton 1
Foggia 1
Frankfurt Am Main 1
Hefei 1
Ho Chi Minh City 1
Las Vegas 1
Leawood 1
Newark 1
Nocera Inferiore 1
Norwalk 1
Oslo 1
Prilep 1
Rome 1
Serra D'aiello 1
Shaoxing 1
Stockholm 1
Taipei 1
Taiyuan 1
Toronto 1
Trieste 1
Vientiane 1
Vittoria 1
Washington 1
Xi'an 1
Yicheng 1
Totale 987
Nome #
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 86
ANTI-INFLAMMATORY ACTION OF DENOSUMAB IN VIVO AND IN VITRO 78
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 76
A new therapy for kidney injury: regeneration. 71
The relationship between coping, emotion regulation, and quality of life of patients on dialysis 69
Before and after preeclampsia: What biomarkers are there? 68
Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease 66
L’ERITROPOIETINA HA AZIONE NEFROPROTETTIVA IN UN MODELLO SPERIMENTALE DI ZEBRAFISH (DANIO RERIO) DOPO SOMMINISTRAZIONE DI GENTAMICINA 64
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system 64
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 64
NEUROTROFINE E PAZIENTI TRAPIANTATI QUALCOSA DI NUOVO? 61
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 61
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 57
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 53
Erithropoietin exerts a renoprotective action in an experimental model of zebrafish (Danio Rerio) after administration of gentamicin 50
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 49
ERYTHROPOIETIN EXERTS A RENOPROTECTIVE ACTION IN AN EXPERIMENTAL MODEL OF ZEBRAFISH (DANIO RERIO) AFTER ADMINISTRATION OF GENTAMICIN 49
Socio-economic factors, food habits and phosphorus levels in patients on hemodialysis 49
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Endothelial Progenitor Cells (EPCs) Evaluation in Aortic Aneurysm Repair. 48
A Biotechnological T-Shirt Monitors the Patient's Heart during Hemodialysis. 48
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 42
NGAL is a precocious marker of therapeutic response. 40
Totale 1.313
Categoria #
all - tutte 5.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 0 0 0 0 0 20 10 7 2 46 11 0
2020/2021131 9 2 50 2 19 4 0 11 7 16 5 6
2021/2022165 0 20 1 12 9 1 14 4 0 36 18 50
2022/2023507 31 63 19 35 64 47 5 37 189 1 11 5
2023/2024125 5 12 4 9 10 49 2 7 0 11 0 16
2024/2025115 19 7 12 31 15 31 0 0 0 0 0 0
Totale 1.313